Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Financing Cash Flow

$32.24M

TTM · Period ending: Jun 30, 2026 · USD

LCTX Financing Cash Flow

Latest reported$32.24Mperiod endingJun 30, 2026

Latest reported$32.24Mperiod endingJun 30, 2026

LCTX TTM Cash from Financing ($0.00 → $32.24M)

TTM financing cash flow

High-resolution chart · PNG

LCTX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	1,615,336
Mar 31, 2001	932,464
Dec 31, 2000	915,964
Sep 30, 2000	780,187
Jun 30, 2000	20,412
Mar 31, 2000	120,412
Dec 31, 1999	7,420,412
Sep 30, 1999	7,800,000
Jun 30, 1999	7,800,000
Mar 31, 1999	7,800,000
Sep 30, 1998	700,000
Jun 30, 1998	900,000
Mar 31, 1998	900,000
Dec 31, 1997	7,000,000
Sep 30, 1997	7,100,000
Jun 30, 1997	6,700,000
Mar 31, 1997	6,700,000
Dec 31, 1996	500,000
Sep 30, 1996	100,000
Sep 30, 1995	-200,000
Jun 30, 1995	-200,000
Mar 31, 1995	-200,000
Dec 31, 1994	3,800,000
Sep 30, 1994	3,900,000
Jun 30, 1994	3,900,000
Mar 31, 1994	3,900,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	-100,000
Mar 31, 1993	-300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.